IP Library › Granted Patent US 12,414,959
Granted Patent B2
US 12,414,959 · App. 17/506,227 · Granted Sep 16, 2025

Glucose infusion solution composition

Inventors: Geon Moo Lee (Gwangju, KR); In Seong Lee (Gwangju, KR); Jun Seong Lee (Gwangju, KR); Mi Boon Chung (Seoul, KR); Jin Kyu Song (Gwangju, KR)
A61K31/7004A61K9/08A61K31/7008A61K47/183
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,414,959
App. No.
17/506,227
Granted
Sep 16, 2025
Kind
B2
Abstract

An infusion solution composition having enhanced stability is disclosed.

Claims (5)

1. A method for promoting health, consisting of:

administering to a subject an intravenous injection comprising glucose, galactose, mannose, L-fucose, xylose, N-acetylglucosamine, N-acetylgalactosamine, N-acetylneuraminic acid, and a stabilizer, wherein the stabilizer is aspartic acid.

2. A method for promoting health, consisting of:

administering to a subject an intravenous injection comprising glucose, galactose, mannose, L-fucose, xylose, N-acetylglucosamine, N-acetylgalactosamine, and N-acetylneuraminic acid,

wherein the intravenous injection comprises methionine, phenylalanine, histidine, and aspartic acid as stabilizers.

Priority Claims (1)
KR 10-2017-0032477 · Mar 15, 2017 · national
Continuity (2)
Continuation 16493004
Related Publication 20220031718A1 · Feb 3, 2022
References Cited (20)
US 4670261A · Samejima et al. · 1987 [cited by applicant]
US 6812222B1 · Wu et al. · 2004 [cited by applicant]
US 20020150666A1 · Kampinga et al. · 2002 [cited by applicant]
US 20160022713A1 · Wang · 2016 [cited by applicant]
US 20200188686A1 · Kalmeta · 2020 [cited by applicant]
CN 85107296A · 1987 [cited by applicant]
CN 103284156A · 2013 [cited by applicant]
KR 1019890002948 · 1989 [cited by applicant]
KR 1020110087614A · 2011 [cited by applicant]
KR 101672347B1 · 2016 [cited by applicant]
WO WO2015200027A1 · 2015 [cited by applicant]
International Search Report from corresponding PCT Application No. PCT/KR2018/002918, mailed on Jun. 11, 2018. [cited by applicant]
Extended European Search Report from corresponding European Patent Application No. 18768107.7, dated Aug. 13, 2020. [cited by applicant]
Office Action (Non-Final) from corresponding U.S. Appl. No. 16/493,004, dated Sep. 16, 2020. [cited by applicant]
Office Action (Final) from corresponding U.S. Appl. No. 16/493,004, dated Apr. 21, 2021. [cited by applicant]
Lee, M. H., Lin, Y. S., Tu, C. F., & Yen, C.H. (2014). Recombinant human factor IX produced from transgenic porcine milk. BioMed research international, 2014. (Year: 2014). [cited by applicant]
Wu, G., & Knabe, D. A. (1994). Free and protein-bound amino acids in saw's colostrum and milk. The Journal of nutrition, 124(3), 415-424. (Year: 1994). [cited by applicant]
Bell, F. R., & McLeay, L. M. (1978). The effect of duodenal infusion of milk, casein, lactose and fat on gastric emptying and acid secretion in the milk-fed calf. The Journal of Physiology, 282(1), 51-57. (Year: 1978). [cited by applicant]
Increased Thermal Stability of Proteins in the Presence of Sugars and Polyols; Joan F. Back et al., Biochemistry, vol. 18, No. 23, pp. 5191˜5196 (Nov. 13, 1979). [cited by applicant]
“Food Chemical principle”, Chen, Xiangyun et al., p. 145, University Press of South Chinese Technology, Feb. 28, 2015. [cited by applicant]